Skip to content

Research Grants

NPF raises and directs funds to support exemplary research projects in the field of pancreas disease.

The deadline for the current 2017 research grant cycle is January 31, 2017.

The National Pancreas Foundation (NPF) is a private, non-profit organization established to support the funding of research related to pancreatic diseases. It also provides support for the men, women, and children who are suffering from diseases of the pancreas.

Applicants should complete the original 2017 NPF Grant Application (DOC).  International applicants at accredited universities are also encouraged to apply. Using a single electronic file (Microsoft Word or Adobe PDF format), the application format should be as follows using the headings listed below.


  • Title
  • Abstract: limited to 300 words
  • Specific Aims: maximum of one page with a clear description of the hypothesis being tested
  • Background and Significance (maximum of two pages and should adequately cite literature pertinent to the area under investigation
  • Preliminary Data: If this application represents a resubmission, a description of what new information or data should be clearly outlined as well as any publications citing the NPF. Maximum of two pages.
  • Proposed Studies and Methods: Anticipated results and pitfalls should also be included. Maximum of three pages.
  • Literature cited
  • Budget Justification: Not more than one page. Justification for salary support and supplies and equipment listed in the budget page should be detailed.
  • Biosketch and Other Support (maximum of 3 pages per investigator) should be submitted in NIH format for the Principal Investigator and other investigators listed in the application. Potential overlap with other funding should be clearly detailed.
  • The application should be submitted via electronic version as a single file in Microsoft Word or Adobe PDF format should be submitted from the NPF website at
  • The Principal Investigator and the Institutional Representative must sign the application before it will be accepted for review.
  • The Abstract portion of the application should contain enough information to adequately explain the project and its relevance to the pancreas.
  • The budget should be inclusive and for direct costs only. Justification is needed for all equipment purchases over $ 500.00.

The Attestation Statement must be read and signed by the Principal Investigator. Item number 6 refers to the Investigator’s commitment that the research will be conducted under the supervision of an Institution at which appropriate standards and oversights are working.


Please submit the application via electronic file in Microsoft Word or Adobe PDF format as described above to the NPF website here We will only accept applications electronically please do not mail a paper copy to the NPF office. 

2017 NPF Grant Application (DOC)

2017 Grant Application (PDF)

Applications are due January 31, 2018

Notification The notification of the decision of the Board of Directors regarding funding will be mailed to the applicant and the Institutional Representative after the Board meets, usually in late April or early May.



2016 Grant Recipients

2016 Grant Recipients

The National Pancreas Foundation is pleased to announce our 2016 grant recipients. We are hopeful that these projects will bring us one step closer to unlocking the mysteries of pancreatic disease.

 Magnetic Resonance Cholangiopancreatography (MRCP) A Reliable, Non Invasive Method for Staging Chronic Pancreatitis from Minimal Change Disease to the Advanced Stages in Pediatrics
Abu-El-Haija, Maisam, MD; Trout, Andrew, MD
Cincinnati Children’s Hospital Medical Center 
 A Novel Biomarker, mAB Das-1, for Diagnosis and Risk Stratification of Precancerous Pancreatic Lesions*
Das, Kiron, MD
Rutgers, the State University of New Jersey
*Supported by the Allen Lebovitz and Esther Horvitz Pancreatic Cancer Research Fund 

Genomic Structural Variants at the CTRB1/CTRB2 Locus in Chronic Pancreatitis

Hegyi, Eszter, MD, PhD
Boston University, Henry M. Goldman School of Dental Medicine 
Preoperative Extended Chemotherapy vs. Chemotherapy Plus Hypofractionated Radiation Therapy for Borderline Resectable Adenocarcinoma of the Head of the Pancreas*
Katz, Matthew, MD FACS
University of Texas/MD Anderson Cancer Center
*Supported by the Western PA National Pancreas Foundation Chapter

Non-Tumorigenic Support Cells Fuel Pancreatic Cancer Metabolism 

Lyssiotis, Costas, PhD
Regents of the University of Michigan 
Engineered T Cells for Pancreatic Cancer*
Watanabe, Norihiro, PhD
Baylor College of Medicine
*Supported by the Ben & Rose Cole Pria Foundation